Entity family
Named medicines, compounds, vaccines, and pharmacological agents. Examples include metformin, semaglutide, antibiotics.
This drug is selected. Its supporting articles are shown below.
…a mineralocorticoid receptor antagonist (MRA), 445 (69.5%) on a RAAS-inhibitor, and 414 (64.7%) on a SGLT2-inhibitor respectively. Overall, 21…
…and diagnostic services and were less likely to be dispensed an ACE inhibitor or mineralocorticoid receptor antagonist after adjusting for re…
…ciety of Cardiology (ESC) 2021 guidelines, which consisted of a renin-angiotensin system inhibitor, a beta-blocker, a mineralocorticoid receptor antagonist and a …
…ary 2009 to 31 December 2018. We evaluated non-adherence to any ACE inhibitor, angiotensin receptor blocker, β-blocker or mineralocorticoid r…